Shenyang Xingqi Pharmaceutical Hits Day High with 4.66% Surge

Shenyang Xingqi Pharmaceutical Co., Ltd. has experienced a notable increase of 4.66% on July 1, 2026, reaching an intraday high of CNY 42.75. This performance stands out against the backdrop of the China Shanghai Composite, which only saw a modest gain of 0.44% on the same day. Over the past week, Shenyang Xingqi has shown a robust performance with an 8.08% increase, while its monthly performance has climbed to 9.92%. Year-to-date, however, the stock has faced a decline of 12.0%, contrasting with the Shanghai Composite's positive return of 3.62%. The company's financial health is underscored by a significant net profit growth of 41.48% reported in March, alongside a remarkable operating cash flow of CNY 771.22 million. With a return on equity of 34.62% and a price-to-book ratio of 4.48, Shenyang Xingqi maintains a solid market position within the pharmaceuticals and biotechnology sector. The stock's dividend yield stands at 2.25%, reflecting its commitment to returning value to shareholders.